-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
INTEGRATED BIOPHARMA INC quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2011 to Q3 2025.
- INTEGRATED BIOPHARMA INC Depreciation, Depletion and Amortization for the quarter ending 30 Sep 2025 was $77K, a 9.41% decline year-over-year.
- INTEGRATED BIOPHARMA INC annual Depreciation, Depletion and Amortization for 2025 was $318K, a 3.58% increase from 2024.
- INTEGRATED BIOPHARMA INC annual Depreciation, Depletion and Amortization for 2024 was $307K, a 12.5% decline from 2023.
- INTEGRATED BIOPHARMA INC annual Depreciation, Depletion and Amortization for 2023 was $351K, a 4.46% increase from 2022.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)